Suppr超能文献

帕金森病相关蛋白 CHCHD2 的缺失会影响线粒体嵴结构并使细胞色素 c 不稳定。

Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.

机构信息

Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.

Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.

出版信息

Nat Commun. 2017 Jun 7;8:15500. doi: 10.1038/ncomms15500.

Abstract

Mutations in CHCHD2 have been identified in some Parkinson's disease (PD) cases. To understand the physiological and pathological roles of CHCHD2, we manipulated the expression of CHCHD2 in Drosophila and mammalian cells. The loss of CHCHD2 in Drosophila causes abnormal matrix structures and impaired oxygen respiration in mitochondria, leading to oxidative stress, dopaminergic neuron loss and motor dysfunction with age. These PD-associated phenotypes are rescued by the overexpression of the translation inhibitor 4E-BP and by the introduction of human CHCHD2 but not its PD-associated mutants. CHCHD2 is upregulated by various mitochondrial stresses, including the destabilization of mitochondrial genomes and unfolded protein stress, in Drosophila. CHCHD2 binds to cytochrome c along with a member of the Bax inhibitor-1 superfamily, MICS1, and modulated cell death signalling, suggesting that CHCHD2 dynamically regulates the functions of cytochrome c in both oxidative phosphorylation and cell death in response to mitochondrial stress.

摘要

CHCHD2 基因突变已在一些帕金森病(PD)病例中被发现。为了了解 CHCHD2 的生理和病理作用,我们在果蝇和哺乳动物细胞中操纵 CHCHD2 的表达。CHCHD2 在果蝇中的缺失导致线粒体基质结构异常和氧呼吸受损,导致氧化应激、多巴胺能神经元丧失和运动功能障碍随年龄增长而恶化。这些与 PD 相关的表型可通过翻译抑制剂 4E-BP 的过表达和人 CHCHD2 的引入得到挽救,但不能通过其与 PD 相关的突变体得到挽救。CHCHD2 在果蝇中受到各种线粒体应激的上调,包括线粒体基因组的不稳定和未折叠蛋白应激。CHCHD2 与细胞色素 c 结合,同时与 Bax 抑制剂-1 超家族的一个成员 MICS1 结合,并调节细胞死亡信号,表明 CHCHD2 动态调节细胞色素 c 的功能,以应对线粒体应激,在氧化磷酸化和细胞死亡中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a67f/5467237/47bb8b517a67/ncomms15500-f1.jpg

相似文献

2
Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson's Disease.
Cell Stem Cell. 2016 Dec 1;19(6):709-724. doi: 10.1016/j.stem.2016.08.002. Epub 2016 Sep 8.
4
Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
Mol Neurobiol. 2024 Oct;61(10):7968-7988. doi: 10.1007/s12035-024-04090-y. Epub 2024 Mar 7.
5
PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Hum Mol Genet. 2019 Apr 1;28(7):1100-1116. doi: 10.1093/hmg/ddy413.
6
Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants.
Hum Mutat. 2017 Aug;38(8):978-987. doi: 10.1002/humu.23234. Epub 2017 May 22.
7
Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson's disease.
Cell Death Dis. 2016 Jun 23;7(6):e2271. doi: 10.1038/cddis.2016.173.
8
Mutations in CHCHD2 cause α-synuclein aggregation.
Hum Mol Genet. 2019 Dec 1;28(23):3895-3911. doi: 10.1093/hmg/ddz241.

引用本文的文献

1
Qigu capsule alleviates dexamethasone-induced muscle dysfunction through mitochondrial biogenesis.
J Tradit Chin Med. 2025 Aug;45(4):739-746. doi: 10.19852/j.cnki.jtcm.2025.04.004.
2
Structures and functions of the MICOS: Pathogenesis and therapeutic implications in Alzheimer's disease.
Acta Pharm Sin B. 2025 Jun;15(6):2966-2984. doi: 10.1016/j.apsb.2025.04.019. Epub 2025 Apr 22.
4
Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson's Disease.
Int J Mol Sci. 2025 May 7;26(9):4451. doi: 10.3390/ijms26094451.
8
Mitochondrial dysfunction in Parkinson's disease.
J Neural Transm (Vienna). 2024 Dec;131(12):1415-1428. doi: 10.1007/s00702-024-02863-2. Epub 2024 Nov 25.
9
A comprehensive review of natural compounds and their structure-activity relationship in Parkinson's disease: exploring potential mechanisms.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2229-2258. doi: 10.1007/s00210-024-03462-4. Epub 2024 Oct 11.
10
CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.
bioRxiv. 2024 Aug 31:2024.08.30.610586. doi: 10.1101/2024.08.30.610586.

本文引用的文献

1
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
Neurology. 2015 Dec 8;85(23):2016-25. doi: 10.1212/WNL.0000000000002170. Epub 2015 Nov 11.
3
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
Lancet Neurol. 2015 Mar;14(3):274-82. doi: 10.1016/S1474-4422(14)70266-2. Epub 2015 Feb 4.
5
CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation.
Cell Death Differ. 2015 Jun;22(6):1035-46. doi: 10.1038/cdd.2014.194. Epub 2014 Dec 5.
6
Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering.
PLoS Genet. 2014 Dec 4;10(12):e1004861. doi: 10.1371/journal.pgen.1004861. eCollection 2014 Dec.
7
MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism.
Mitochondrion. 2015 Jan;20:43-51. doi: 10.1016/j.mito.2014.10.003. Epub 2014 Oct 12.
8
Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila.
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2967-76. doi: 10.1073/pnas.1405500111. Epub 2014 Jul 7.
9
A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
Brain. 2014 Aug;137(Pt 8):2329-45. doi: 10.1093/brain/awu138. Epub 2014 Jun 16.
10
PINK1-mediated phosphorylation of Parkin boosts Parkin activity in Drosophila.
PLoS Genet. 2014 Jun 5;10(6):e1004391. doi: 10.1371/journal.pgen.1004391. eCollection 2014 Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验